M Potmĕsil
Impact in
- Toxicology top 0.2%
- Bioactive Compounds and Antitumor Agents
- Oncology top 2%
- Lung Cancer Research Studies
- Neutropenia and Cancer Infections
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
Papers in
-
- Cancer therapeutics and mechanisms 26
- RNA modifications and cancer 6
- Oncology 23
- Lung Cancer Research Studies 5
- Cancer Treatment and Pharmacology 5
- Co-authors
- Leroy F. Liu (7 shared papers)R Silber (12 shared papers)Monroe E. Wall (4 shared papers)Allan W. Nicholas (2 shared papers)John S. Stehlin (5 shared papers)Robert Silber (6 shared papers)Alexander S. Thomas (4 shared papers)S Kirschenbaum (8 shared papers)
- Journals
- Blood (4 papers)Radiation Research (3 papers)Cell Proliferation (2 papers)Annals of the New York Academy of Sciences (2 papers)Journal of Gastrointestinal Surgery (2 papers)
- Partner nations
- United StatesSwitzerlandChina
In The Last Decade
M Potmĕsil
60 papers receiving 3.3k citations
M Potmĕsil's Hit Papers
Peers
Comparison fields: 5 of 105
- Toxicology 434
- Oncology 1.4k
- Genetics 446
- Molecular Biology 2.4k
- Pharmacology 235
Countries citing papers authored by M Potmĕsil
This map shows the geographic impact of M Potmĕsil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Potmĕsil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Potmĕsil more than expected).
Fields of papers citing papers by M Potmĕsil
This network shows the impact of papers produced by M Potmĕsil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Potmĕsil. The network helps show where M Potmĕsil may publish in the future.
Co-authors
The 25 scholars most cited alongside M Potmĕsil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | DNA Topoisomerase I—Targeted Chemotherapy of Human Colon Cancer in Xenografts Hit paper breakdown → | 1989 | 598 |
| 2 | DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues. | 1989 | 321 |
| 3 | 1993 | 314 | |
| 4 | Camptothecins: from bench research to hospital wards. | 1994 | 287 |
| 5 | Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. | 1996 | 250 |
| 6 | DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA. | 1989 | 217 |
| 7 | Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)-camptothecin. | 1991 | 169 |
| 8 | Camptothecins New Anticancer Agents | 1994 | 161 |
| 9 | Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II. | 1988 | 152 |
| 10 | Camptothecin overcomes MDR1-mediated resistance in human KB carcinoma cells. | 1991 | 149 |
| 11 | Antiangiogenic effects of camptothecin analogues 9-amino-20(S)-camptothecin, topotecan, and CPT-11 studied in the mouse cornea model. | 1999 | 90 |
| 12 | A further contribution to the demonstration of RNA and nucleoli of blood cells in smear preparations. | 1969 | 66 |
| 13 | 1994 | 61 | |
| 14 | Protein-associated DNA breaks and DNA-protein cross-links caused by DNA nonbinding derivatives of adriamycin in L1210 cells. | 1981 | 51 |
| 15 | Relationship of adriamycin concentrations to the DNA lesions induced in hypoxic and euoxic L1210 cells. | 1983 | 42 |
| 16 | 1984 | 39 | |
| 17 | Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan. | 1998 | 33 |
| 18 | 2002 | 32 | |
| 19 | 1968 | 27 | |
| 20 | Growth inhibition of human cancer metastases by camptothecins in newly developed xenograft models. | 1995 | 26 |
About M Potmĕsil
M Potmĕsil is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Genetics and Immunology, having authored 61 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (26 papers), Chronic Lymphocytic Leukemia Research (9 papers), RNA modifications and cancer (6 papers), Lung Cancer Research Studies (5 papers), Gastric Cancer Management and Outcomes (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Cancer Treatment and Pharmacology (5 papers) and Acute Lymphoblastic Leukemia research (4 papers). The work is most often cited by research in Toxicology (434 citations), Oncology (1.4k citations), Genetics (446 citations), Molecular Biology (2.4k citations) and Pharmacology (235 citations). M Potmĕsil has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Leroy F. Liu, R Silber, Monroe E. Wall, Allan W. Nicholas, John S. Stehlin, Robert Silber, Alexander S. Thomas, S Kirschenbaum, Soumaya El Rouby and Herbert M. Pinedo. Their work appears in journals such as Blood, Radiation Research, Cell Proliferation, Annals of the New York Academy of Sciences and Journal of Gastrointestinal Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.